Data for Regeneron arthritis drug in coronavirus could come in weeks
Regeneron could release data within weeks about how well its arthritis drug Kevzara is battling the new coronavirus, its chief scientific officer said during a STAT video chat Wednesday.
George Yancopoulos, who is also the Tarrytown, N.Y.-based biotech’s co-founder, made it clear during the chat that the battle, for him, is personal.
“I can’t believe the devastation we’re facing here in New York, at the epicenter, and the bad news is so many people have already died and are in hospitals, and are on ventilators,” said Yancopoulos,, who grew up in Queens. He used that
